NAPT Honors Congressman Scott Peters with Inaugural Champion Award for Proton Therapy Advocacy
SAN DIEGO, CA — April 23, 2024.— The National Association for Proton Therapy (NAPT), the nation’s leading organization dedicated to increasing patient access to proton therapy, today announced it has awarded its inaugural Champion Award to U.S. Rep. Scott Peters (D-CA) for his steadfast efforts to safeguard patient access to proton therapy.
The Champion Award is reserved for public officials and others who are recognized for legislative and regulatory achievements toward advancing the field of proton therapy and galvanizing support among policymakers.
“Through his bipartisan efforts to address potential challenges in CMS’ Radiation Oncology Alternative Payment Model, Congressman Peters exemplifies dedication to ensuring that advances in radiotherapy remain accessible to those in need,” said NAPT Executive Director Jennifer Maggiore. “His leadership has not only had a significant impact on policy but also underscores the importance of bipartisan support for the advancement of innovative cancer treatment technologies.”
Backed by decades of science and delivered by proven technology, proton therapy reduces side effects and improves quality-of-life for cancer patients and survivors. Proton therapy is highly targeted, delivering a precise dose of radiation to the tumor while sparing healthy tissue – leading to fewer side effects and complications.
At an April 23 award ceremony held at California Protons Cancer Therapy Center in San Diego, Rep. Peters was joined by cancer patient Leticia Della, who at 56 was diagnosed with cancer and found herself overwhelmed by traditional treatment options. After exploring alternatives, Leticia received treatment at California Protons, completing 33 sessions with significantly fewer complications such as incontinence and bone damage. Leticia’s successful recovery highlights the innovative and effective nature of proton therapy in modern cancer care.
“Congressman Peters recognizes the importance of the availability of proton therapy to cancer patients in California and beyond,” said Maggiore. “We are grateful for his continued work to ensure that everyone who needs proton therapy is able to benefit from this life-saving, life-changing treatment.”
The National Association for Proton Therapy (NAPT) is an independent nonprofit organization founded in 1990 to educate and increase awareness about the clinical benefits of proton therapy. Its members include 48 of the nation’s leading cancer centers, many of which are NCI-designated comprehensive cancer centers and NCCN members. The mission of NAPT is to work collaboratively to raise public awareness of the clinical benefits of proton therapy, ensure patient choice and access to affordable proton therapy, and encourage cooperative research and innovation to advance the appropriate and cost-effective utilization of proton therapy.